Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Butuo Xu

2PUBLICATIONS
10CO-AUTHORS
Molecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Sep 07, 2024
Targeting cell death in NAFLD: mechanisms and targeted therapies.

Hui-Li Xu, Sheng-Rong Wan, Ying An

|May 02, 2022
Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway.

Xinyue Li, Butuo Xu, Jing Wu

Pageof 1

Frequent Collaborators

2 joint publications

Shengrong Wan

2 joint publications

Zongzhe Jiang

1 joint publications

Xinyue Li

1 joint publications

Jing Wu

1 joint publications

Yueli Pu

1 joint publications

Yan Zeng

1 joint publications

Mei Wang

1 joint publications

Lifang Luo

1 joint publications

Fanjie Zhang

1 joint publications

Yong Xu

Frequent Collaborators

2 joint publications

Shengrong Wan

2 joint publications

Zongzhe Jiang

1 joint publications

Xinyue Li

1 joint publications

Jing Wu

Top Related Videos

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on : Jul 19, 2024

823
Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

674
See more related videos

Top Related Videos

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on : Jul 19, 2024

823
Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

674
See more related videos